The recent results from the pivotal Phase 3 ROSELLA trial mark a significant development in the battle against platinum-resistant ovarian cancer. Corcept Therapeutics announced that the trial successfully demonstrated the efficacy of combining relacorilant with nab-paclitaxel chemotherapy,
Advancements in artificial intelligence (AI) have facilitated significant progress in heart attack diagnosis, specifically through an AI model trained to identify blocked coronary arteries using electrocardiogram (ECG) readings. This groundbreaking technology has been found to outperform human
The rapid advancement of artificial intelligence (AI) has made significant strides in many sectors, and the realm of healthcare is no exception. Among the promising innovations is the use of AI-powered digital twins in clinical trials, particularly those targeting complex diseases like Amyotrophic
The world of personalized cancer treatment has seen groundbreaking advancements with the introduction of combination immunotherapy, particularly in the realm of metastatic gastrointestinal (GI) cancers. Researchers at the National Cancer Institute (NCI) have developed a transformative approach that
Bayesian methods are revolutionizing the landscape of pediatric clinical trial design by offering flexibility, precision, and ethical considerations that are crucial when dealing with vulnerable populations. These approaches are particularly suited to the unique challenges of pediatric trials,
Medical advancements are progressing rapidly, and one of the most promising areas is artificial intelligence (AI) in diagnostic imaging. AI technology has the potential to revolutionize healthcare by enhancing the accuracy and efficiency of diagnoses. Acer Medical recently introduced two
